Biohaven Ltd.

NYSE:BHVN

Sector

🏥 Health Care

Industries

🔬 Clinical Trials

🧬 Biotechnology

💊 Pharmaceuticals

💻 Telehealth

Location

United States

Market Cap

USD 1.44 B

Share Price

USD 14.09

Avg Daily Volume

2,081,003

Change (1 day)

-4.41%

Change (1 year)

-59.85%

Change (YTD)

-62.28%

Biohaven Ltd. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2025

Biohaven Ltd. Operating Income Margin is NA for the Trailing 12 Months (TTM) ending March 31, 2025. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Biohaven Ltd. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -61.35%, a -91.07% change year over year.
Biohaven Ltd. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -686.85%, a -98.63% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Operating Income Margin	Gross Profit Margin	EBIT Margin	EBITDA Margin

NYSE: BHVN

Biohaven Ltd.

CEO	Dr. Vladimir Coric M.D.
IPO Date	Sept. 23, 2022
Location	United States
Headquarters	215 Church Street
Employees	256
Sector	🏥 Health Care
Industries Clinical Trials 🧬 Biotechnology 💊 Pharmaceuticals 💻 Telehealth

Description

Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.

Similar companies

AbbVie Inc.

USD 182.31

-2.40%

Novo Nordisk A/S

USD 68.56

1.71%

Roche Holding AG

USD 347.50

0.20%

Abbott Laboratories

USD 134.38

0.53%

Novartis AG

USD 120.31

0.29%

AstraZeneca PLC

USD 140.24

0.73%

Merck & Co., Inc.

USD 79.10

0.34%

Amgen Inc.

USD 277.13

-0.71%

Pfizer Inc.

USD 24.19

-0.21%

Gilead Sciences, Inc.

USD 110.67

2.83%

Sanofi

USD 96.65

0.37%

Vertex Pharmaceuticals Incorporated

USD 441.30

-0.47%

Bristol-Myers Squibb Company

USD 46.35

-0.64%

Chugai Pharmaceutical Co., Ltd.

USD 51.91

-1.13%

GSK plc

USD 19.28

0.69%

CSL Limited

USD 153.01

-2.58%

MERCK Kommanditgesellschaft auf Aktien

USD 131.98

1.04%

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.00%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

-0.32%

Takeda Pharmaceutical Company Limited

USD 30.16

-0.03%

Alnylam Pharmaceuticals, Inc.

USD 322.83

1.44%

UCB SA

USD 199.41

0.97%

GE HealthCare Technologies Inc.

USD 74.38

-0.64%

Bayer AG

USD 31.61

2.81%

Celltrion, Inc.

USD 116.73

-0.46%

WuXi AppTec Co., Ltd.

USD 9.68

-1.75%

Hansoh Pharmaceutical Group Company Limited

USD 3.71

-0.01%

Laboratory Corporation of America Holdings

USD 260.59

1.41%

Insmed Incorporated

USD 99.49

-2.21%

Royalty Pharma plc

USD 35.87

1.70%

Biogen Inc.

USD 126.08

-0.66%

Astellas Pharma Inc.

USD 9.69

0.99%

Innovent Biologics, Inc.

USD 9.85

-1.60%

Summit Therapeutics Inc.

USD 20.60

-3.38%

Shionogi & Co., Ltd.

USD 17.51

-0.68%

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

Genmab A/S

USD 205.20

-0.79%

Neurocrine Biosciences, Inc.

USD 125.42

-1.02%

Exelixis, Inc.

USD 43.67

1.35%

Mankind Pharma Limited

USD 27.30

1.56%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.56

0.65%

Regencell Bioscience Holdings Limited

USD 17.40

-13.82%

Akeso, Inc.

USD 11.78

-2.48%

Ascendis Pharma A/S

USD 172.22

-0.42%

Lupin Limited

USD 22.64

0.60%

BioMarin Pharmaceutical Inc.

USD 55.17

1.98%

Swedish Orphan Biovitrum AB (publ)

USD 29.88

2.57%

Ipsen S.A.

USD 120.09

-0.15%

Huadong Medicine Co., Ltd

USD 5.63

0.53%

StockViz Staff

June 30, 2025

Any question? Send us an email